search
Back to results

Walking and Balance Post-TBI

Primary Purpose

Difficulties, Ambulation, Brain Injuries, Traumatic

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Intensive Mobility Training (IMT)
Sponsored by
INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Difficulties, Ambulation focused on measuring physical therapy techniques, brain injuries, traumatic, walking, gait, postural balance

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. greater than 3 months post-TBI (as defined by INTRuST criteria) and no longer receiving care as an inpatient in a rehabilitation facility.
  2. the ability to follow simple three-step commands;
  3. the ability to communicate presence and location of pain;
  4. the ability to sit independently without back or arm support for five minutes;
  5. the ability to stand with support of a straight cane, quad cane, or walker for 2 minutes;
  6. the ability to walk 10 meters with maximum 1 person assisting;
  7. presence of motor deficits (determined by clinical assessment of paresis);
  8. age ≥ 18;
  9. ability to give consent or have a acceptable surrogate capable of giving consent on subject's behalf

Exclusion Criteria:

  1. unable to ambulate 500 feet prior to TBI;
  2. history of serious chronic obstructive pulmonary disease or oxygen dependence;
  3. severe weight bearing pain;
  4. lower-extremity amputation;
  5. non-healing ulcers on the lower-extremity;
  6. renal dialysis or end stage liver disease;
  7. legal blindness or severe visual impairment;
  8. severe arthritis or orthopedic problems that limit passive ranges of motion of lower extremity (knee flexion contracture of -10°, knee flexion Range of Motion < 90°, hip flexion contracture > 25°, and ankle plantar flexion contracture > 15°);
  9. history of deep venous thrombosis or pulmonary embolism within 6 months
  10. uncontrollable diabetes with recent weight loss, diabetic coma, or frequent insulin reactions;
  11. severe hypertension with systolic greater than 200 mmHg and diastolic greater than 110 mmHg at rest;
  12. intracranial hemorrhage related to aneurysm rupture or an arteriovenous malformation (hemorrhagic infarctions will not be excluded);
  13. history of severe uncontrolled seizure disorder;
  14. other neurological conditions such as multiple sclerosis or Parkinson's Disease;
  15. pain that is scored greater than 5 out of 10 on a visual analog scale;
  16. any factor contraindicative to MRI examination (e.g., cardiac pacemaker/ defibrillator, pregnancy, aneurysm clips, insulin pump, metal fragments in the body).
  17. any other health problems judged by their screening physician to put the client at significant risk of harm during the study

Sites / Locations

  • 921 Assembly Street, 3rd Floor, Public Health Research Center, University of South Carolina

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Intensive Mobility Training (IMT)

Arm Description

Intensive Mobility Training will be used as an intensive physical therapy intervention. Participants will receive 3 hours per day for a 10 day session, be post-tested, and receive another 10 day session followed by two more testing sessions.

Outcomes

Primary Outcome Measures

Feasibility as measured by study completion.
Feasibility will be determined by the ratio of participants that complete the intervention.
Feasibility as measured by pain ratings.
Feasibility will be determined by daily change in pain scores as measured using visual analog scales.
Feasibility as measured by fatigue ratings.
Feasibility will be determined by daily change in fatigue scores as measured using visual analog scales.

Secondary Outcome Measures

Efficacy as measured by improvements in gait and mobility.
Efficacy will be measured by improvements in mobility and gait as measured by the Dynamic Gait Index, Timed Up and Go, Six- Minute Walk, and Falls Efficacy Scale.

Full Information

First Posted
August 16, 2011
Last Updated
April 25, 2013
Sponsor
INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium
Collaborators
U.S. Army Medical Research and Development Command
search

1. Study Identification

Unique Protocol Identification Number
NCT01418976
Brief Title
Walking and Balance Post-TBI
Official Title
IMPROVING WALKING AND BALANCE IN VETERANS WITH TRAUMATIC BRAIN INJURY: A PILOT STUDY EXAMINING FEASIBILITY AND DOSAGE
Study Type
Interventional

2. Study Status

Record Verification Date
April 2013
Overall Recruitment Status
Completed
Study Start Date
July 2011 (undefined)
Primary Completion Date
March 2013 (Actual)
Study Completion Date
March 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium
Collaborators
U.S. Army Medical Research and Development Command

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is a case series study evaluating the feasibility and dosage of Intensive Mobility Training (IMT). Twelve participants with chronic, mild-to-moderate, Traumatic Brain Injury (TBI) causing significant locomotor impairment, who meet these specific criteria, will be recruited. Location and nature of neural insult will be determined by multimodal Magnetic Resonance Imaging (MRI) exam. All participants will receive 3 hours of rehabilitation per day for 20 days, focusing on gait and balance. Locomotion and balance will be comprehensively tested prior to IMT, after 10 days of IMT, and then again after the full dose of IMT. This study will determine the feasibility of this intervention in the population of TBI patients, allow an estimate of effect size and provide initial information on possible neural predictors of success. Furthermore the investigators will be able to determine whether the dosage of 10 days is sufficient or whether significant improvements are made with 20 days of the intervention.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Difficulties, Ambulation, Brain Injuries, Traumatic
Keywords
physical therapy techniques, brain injuries, traumatic, walking, gait, postural balance

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
11 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intensive Mobility Training (IMT)
Arm Type
Experimental
Arm Description
Intensive Mobility Training will be used as an intensive physical therapy intervention. Participants will receive 3 hours per day for a 10 day session, be post-tested, and receive another 10 day session followed by two more testing sessions.
Intervention Type
Behavioral
Intervention Name(s)
Intensive Mobility Training (IMT)
Intervention Description
Intensive Mobility Training will be used as an intensive physical therapy intervention. Participants will receive 3 hours per day for a 10 day session, be post-tested, and receive another 10 day session followed by two more testing sessions.
Primary Outcome Measure Information:
Title
Feasibility as measured by study completion.
Description
Feasibility will be determined by the ratio of participants that complete the intervention.
Time Frame
post-treatment (after 20-day intervention)
Title
Feasibility as measured by pain ratings.
Description
Feasibility will be determined by daily change in pain scores as measured using visual analog scales.
Time Frame
during 20-day intervention
Title
Feasibility as measured by fatigue ratings.
Description
Feasibility will be determined by daily change in fatigue scores as measured using visual analog scales.
Time Frame
during 20-day intervention
Secondary Outcome Measure Information:
Title
Efficacy as measured by improvements in gait and mobility.
Description
Efficacy will be measured by improvements in mobility and gait as measured by the Dynamic Gait Index, Timed Up and Go, Six- Minute Walk, and Falls Efficacy Scale.
Time Frame
from pre- to post-treatment during 20-day intervention.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: greater than 3 months post-TBI (as defined by INTRuST criteria) and no longer receiving care as an inpatient in a rehabilitation facility. the ability to follow simple three-step commands; the ability to communicate presence and location of pain; the ability to sit independently without back or arm support for five minutes; the ability to stand with support of a straight cane, quad cane, or walker for 2 minutes; the ability to walk 10 meters with maximum 1 person assisting; presence of motor deficits (determined by clinical assessment of paresis); age ≥ 18; ability to give consent or have a acceptable surrogate capable of giving consent on subject's behalf Exclusion Criteria: unable to ambulate 500 feet prior to TBI; history of serious chronic obstructive pulmonary disease or oxygen dependence; severe weight bearing pain; lower-extremity amputation; non-healing ulcers on the lower-extremity; renal dialysis or end stage liver disease; legal blindness or severe visual impairment; severe arthritis or orthopedic problems that limit passive ranges of motion of lower extremity (knee flexion contracture of -10°, knee flexion Range of Motion < 90°, hip flexion contracture > 25°, and ankle plantar flexion contracture > 15°); history of deep venous thrombosis or pulmonary embolism within 6 months uncontrollable diabetes with recent weight loss, diabetic coma, or frequent insulin reactions; severe hypertension with systolic greater than 200 mmHg and diastolic greater than 110 mmHg at rest; intracranial hemorrhage related to aneurysm rupture or an arteriovenous malformation (hemorrhagic infarctions will not be excluded); history of severe uncontrolled seizure disorder; other neurological conditions such as multiple sclerosis or Parkinson's Disease; pain that is scored greater than 5 out of 10 on a visual analog scale; any factor contraindicative to MRI examination (e.g., cardiac pacemaker/ defibrillator, pregnancy, aneurysm clips, insulin pump, metal fragments in the body). any other health problems judged by their screening physician to put the client at significant risk of harm during the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stacy Fritz, Ph.D., P.T.
Organizational Affiliation
University of South Carolina
Official's Role
Principal Investigator
Facility Information:
Facility Name
921 Assembly Street, 3rd Floor, Public Health Research Center, University of South Carolina
City
Columbia
State/Province
South Carolina
ZIP/Postal Code
29208
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Walking and Balance Post-TBI

We'll reach out to this number within 24 hrs